Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWNarlaprevir is an inhibitor of hepatitis C virus (HCV) non-structural protein 3 (NS3; Ki = 6 nM).1 It also inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro), also known as 3C-like protease (3CLpro; IC50 = 16.11 µM).2 Narlaprevir inhibits HCV replication in a cell-based replicon assay (EC90 = 40 nM) and SARS-CoV-2 replication in Vero cells (EC50 = 7.43 µM).1,2
WARNING This product is not for human or veterinary use.
1. Discovery of narlaprevir (SCH 900518): A potent, second generation HCV NS3 serine protease inhibitor. ACS Med. Chem. Lett. 1(2), 64-69 (2010).
2. Structural basis for the inhibition of the SARS-